Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating an updated page revision. This reflects a metadata update rather than a change to the study information itself.
    Difference
    0.0%
    Check dated 2026-06-26T19:34:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants'); the Intervention/Treatment label was updated and the revision/version updated from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-12T13:27:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, signaling a new release of the site components.
    Difference
    0.0%
    Check dated 2026-06-05T08:30:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page's revision has been updated from v3.5.3 to v3.5.4, signaling a new revision of the document. This appears to be a minor, non-user-facing update rather than a change to content or features.
    Difference
    0.0%
    Check dated 2026-05-14T23:10:25.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333423 was updated to Taoyuan, Taiwan, 333423 in the locations list. The postal code remains 333423.
    Difference
    0.0%
    Check dated 2026-05-07T22:22:30.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Study availability was updated by adding and removing certain clinical trial sites/locations, including changes to specific cities and administrative regions (e.g., in Chile, Finland, and Romania). The record also reflects an updated data-sharing detail setup around providing anonymized participant data under the study’s IPD plan.
    Difference
    0.8%
    Check dated 2026-04-23T21:54:06.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.